Insulet (NASDAQ:PODD) Coverage Initiated by Analysts at Truist Financial
Analysts at Truist Financial initiated coverage on shares of Insulet (NASDAQ:PODD – Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $365.00 price target on the medical instruments supplier’s stock. Truist Financial’s price target suggests a potential upside of 19.91% from the company’s previous […]
Analysts at Truist Financial initiated coverage on shares of Insulet (NASDAQ:PODD – Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The firm set a “buy” rating and a $365.00 price target on the medical instruments supplier’s stock. Truist Financial’s price target suggests a potential upside of 19.91% from the company’s previous […]
